Mja cover 150816

Issues

Volume 205 Issue 4

15 August 2016

News

Cancer 15 August 2016 From Cancer Australia Free

Cancer control’s new STaR

Cancer Australia, in collaboration with leading national, state and territory health organisations and governments, has begun the ambitious STaR project to access and report national data on cancer Stage at diagnosis, Treatment and Recurrence. The project will greatly enhance our ability as a nation to understand variations in cancer outcomes by stage and treatment across population groups. While cancer registries based on the Australian population have been collecting and reporting high-quality data on cancer incidence and mortality for at least 30 years, there remains a lack of national data on the stage (severity of a cancer) when a patient is first diagnosed, the treatments subsequently applied and the frequency of cancer recurrence after treatment. The successful collection and reporting of STaR data, along with information already being collected on cancer incidence and mortality will provide, for the first time, important information across the journey of patients with cancer. With a better understanding of cancer outcomes by stage and treatment across population groups, we can more accurately address variations in practice. This will be especially valuable in variations in outcome across socio-demographic and culturally and linguistically diverse groups. The data may also assist in determining whether differences in survival can be explained by the treatment provided and patterns of care following diagnosis, which could identify areas for practice improvement. The knowledge gained will inform clinical best practice in cancer control, health services planning and public health policy. The STaR project will initially collect and report on the five cancers of highest incidence in Australia. Where available, data will be analysed by cancer type (site and histology), age and gender, Indigenous status, remoteness, socio-economic status and country of birth. In undertaking the STaR project, Cancer Australia is engaging with state and territory population-based cancer registries, as well as key cancer control stakeholders, including the Australian Institute of Health and Welfare, the Australasian Association of Cancer Registries and state and territory government health departments.

Elizabeth Coad

Perspectives

Medical education

Poem

Editorials

Research

Short reports

Evaluation of the performance and outcomes for the first year of a diabetes rapid access clinic

Diabetes rapid access clinics (DRACs) have been identified by the New South Wales Agency for Clinical Innovation as a key component of an integrated diabetes model of care.1 This cost-effective model provides fast and comprehensive outpatient review and has been shown to circumvent hospital admission, decrease hospital length of stay and improve patient outcomes.2-5 Based on this approach, a nurse practitioner-led DRAC was established in February 2015 at Royal North Shore Hospital (RNSH) in Sydney as a pilot program to assess the suitability of the DRAC for scalability across the Northern Sydney Local Health District (NSLHD). The DRAC is an outpatient clinic, operating on weekdays, which adopts the principle that high-risk patients who present to the emergency department (ED) could be diverted from hospitalisation if they were well enough for outpatient management of their condition (Appendix). Patients are referred from general practice, the ED or the endocrinologist on call and require rapid review (within 72 hours) of complex diabetes problems, such as an episode (or episodes) of severe hypoglycaemia, recurring mild hypoglycaemia or hyperglycaemia not needing hospitalisation. We prospectively collected data during the first year since inception of the DRAC, with a particular focus on reasons for referral and cost evaluation. The study was approved by the NSLHD Human Research Ethics Committee (RESP/16/62). Within the first year of the DRAC pilot program at RNSH, 61 patients attended the clinic. About a quarter of these patients (n = 15) would have been hospitalised had they not been reviewed at the DRAC and they were successfully managed as outpatients. Although these patients met the criteria for admission, they were deemed appropriate for the DRAC by the endocrinologist on call. In addition, 26% of the patients were referred back to general practice, while the remainder required ongoing endocrinologist review. Most patients presented with hyperglycaemia-related problems (n = 40; 66%; Box), including 15 patients with newly diagnosed diabetes. A further 11 patients presented with severe hypoglycaemia. Within 30 days of review at the DRAC, one patient presented to the ED and required hospitalisation. Using a conservative costing approach, whereby patients were assumed to be uncomplicated with an average length of stay of 2.5 days (based on data from the NSLHD Performance Unit), the cost analysis demonstrated that for 15 patients for whom hospitalisation was avoided, about $46 700 would have been incurred in their inpatient stay. The DRAC was established through a restructure of existing services; however, if nursing costs associated with running the DRAC were included (about $23 400), the analysis showed that the cost of management in the clinic was half the cost of an inpatient stay (Box). A nurse practitioner-led DRAC was successfully established at a tertiary referral hospital in NSW. Our preliminary evaluation has demonstrated improved patient outcomes and assistance for general practice in managing ongoing outpatient diabetes-related problems. In addition, for a quarter of patients presenting to the DRAC, hospitalisation was prevented. Future directions include the expansion of the DRAC across the local health district and the incorporation of a “hotline” to assist general practitioners with urgent and complex diabetes management. Box – Royal North Shore Hospital Diabetes Rapid Access Clinic (DRAC) evaluation: overview of patient demographics and cost analysis data Patient demographic No. of patients* Patients seen (February – December 2015) 61 Male 42 Mean age, years (SD) 56 ± 16 Mean glycated haemoglobin value (SD) 9.7% ± 2.5% Mean duration of diabetes, years (SD) 13 ± 13 Type 1 diabetes 14 (23%) Type 2 diabetes 47 (77%) Reason for referral to DRAC Newly diagnosed type 1 diabetes 2 Newly diagnosed type 2 diabetes 13 Hyperglycaemia 25 Hypoglycaemia (severe) 11 Other 10 Cost analysis No. of hospitalisations prevented† 15 (25%) Hospitalisation cost per day $1245 Average length of stay, days 2.5 Total hospitalisation cost that would have been incurred $46 687.50 Cost of nursing at DRAC $23 339.52 Cost management difference $23 347.98 * Data are number of patients unless otherwise indicated. † One patient sent to the emergency department via DRAC — not diabetes related.

Neroli Newlyn · Rachel T McGrath · Gregory R Fulcher

Position statement

Endocrinology 15 August 2016 Free

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Part 1 of a position statement to update the 2000 guidelines and inform the recommended management of men with androgen deficiency

Bu B Yeap · Mathis Grossmann · Robert I McLachlan · David J Handelsman · Gary A Wittert · Ann J Conway · Bronwyn GA Stuckey · Douglas W Lording · Carolyn A Allan · Jeffrey D Zajac · Henry G Burger

Narrative review

Careers

15 August 2016 Free

Mother and son

Professor Ingrid Scheffer and her son Eddie Cliff are passionate about encouraging other clinicians to engage in research to enrich their own lives as well as those of their patients …

Cate Swannell

15 August 2016 Free

Under pressure

Dr David Wilkinson, OAM, works in a field not many of his colleagues recognise or respect …

Cate Swannell

Next Issue Volume 205 Issue 5

View more
Mja cover 050916
News 5 September 2016 From Cochrane Free

Feel better by planting trees and taking up yoga

Steve McDonald · Tari Turner

News 5 September 2016 Free

News briefs

Cate Swannell

Perspectives 5 September 2016 Free

Streamlining ethics review for multisite quality and safety initiatives: national bariatric surgery registry experience

Wendy A Brown · Brittany R Smith · Melissa Boglis · Dianne L Brown · Margaret Anderson · Paul E O'Brien · John J McNeil · Ian D Caterson

Perspectives 5 September 2016 Free

The inequitable burden of group A streptococcal diseases in Indigenous Australians

Philippa J May · Asha C Bowen · Jonathan R Carapetis

Previous Issue Volume 205 Issue 3

View more
Mja cover 010816
News 1 August 2016 From the Heart Foundation Free

Move more, sit less! Time for a national physical activity action plan

Jo Salmon

News 1 August 2016 Free

News briefs

Cate Swannell

Perspectives 1 August 2016 Free

Time to bury “hypertension”

Mark R Nelson

Perspectives 1 August 2016 Free

“Congenital heart health”: how psychological care can make a difference

Nadine A Kasparian · David S Winlaw · Gary F Sholler

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.